CompaniesAstion Pharma

Astion Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

397

By Phase

PHASE1/PHASE2: 1PHASE3: 1PHASE2: 2

By Status

COMPLETED: 3UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
NCT02885766
Hover over trial bars to see details

Recent Trials

NCT02885766Lead Sponsor
Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene
PHASE1/PHASE2Unknown
65 participants
Started: Jul 31, 2016 · Completed: May 31, 2020
NCT00565279Lead Sponsor
Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis
PHASE3Completed
300 participants
Started: Dec 31, 2007 · Completed: Jun 30, 2008
NCT00625521Lead Sponsor
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
PHASE2Completed
32 participants
Started: Nov 30, 2006 · Completed: Jul 31, 2007
NCT00625157Lead Sponsor
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)
PHASE2Completed
Related Companies
Cipher Pharmaceuticals
acquired